Tocqueville Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,875
| Closed | -$208K | – | 706 |
|
|
2019
Q4 | $208K | Sell |
2,875
-46,990
| -94% | -$3.4M | ﹤0.01% | 700 |
|
|
2019
Q3 | $7M | Sell |
49,865
-11,880
| -19% | -$1.67M | 0.09% | 216 |
|
|
2019
Q2 | $11.3M | Sell |
61,745
-780
| -1% | -$143K | 0.15% | 176 |
|
|
2019
Q1 | $9.95M | Sell |
62,525
-19,360
| -24% | -$3.08M | 0.13% | 186 |
|
|
2018
Q4 | $7.84M | Sell |
81,885
-4,565
| -5% | -$437K | 0.12% | 194 |
|
|
2018
Q3 | $12.2M | Sell |
86,450
-10,845
| -11% | -$1.53M | 0.15% | 171 |
|
|
2018
Q2 | $15.2M | Buy |
97,295
+40,940
| +73% | +$6.41M | 0.19% | 137 |
|
|
2018
Q1 | $9.08M | Buy |
56,355
+19,055
| +51% | +$3.07M | 0.12% | 194 |
|
|
2017
Q4 | $6.14M | Sell |
37,300
-21,600
| -37% | -$3.56M | 0.07% | 278 |
|
|
2017
Q3 | $3.67M | Sell |
58,900
-12,550
| -18% | -$782K | 0.04% | 370 |
|
|
2017
Q2 | $5.69M | Buy |
71,450
+10,400
| +17% | +$828K | 0.07% | 276 |
|
|
2017
Q1 | $4.34M | Sell |
61,050
-2,000
| -3% | -$142K | 0.05% | 312 |
|
|
2016
Q4 | $3.22M | Buy |
63,050
+18,675
| +42% | +$953K | 0.04% | 352 |
|
|
2016
Q3 | $2.04M | Buy |
44,375
+4,850
| +12% | +$223K | 0.02% | 407 |
|
|
2016
Q2 | $1.19M | Hold |
39,525
| – | – | 0.01% | 484 |
|
|
2016
Q1 | $1.27M | Buy |
39,525
+650
| +2% | +$20.8K | 0.02% | 467 |
|
|
2015
Q4 | $2.27M | Buy |
38,875
+5,775
| +17% | +$337K | 0.03% | 401 |
|
|
2015
Q3 | $1.4M | Buy |
33,100
+10,400
| +46% | +$440K | 0.02% | 492 |
|
|
2015
Q2 | $1.66M | Buy |
22,700
+6,325
| +39% | +$462K | 0.02% | 485 |
|
|
2015
Q1 | $823K | Buy |
+16,375
| New | +$823K | 0.01% | 621 |
|